COSCIENS Biopharma Inc 6-K/A, filed Dec 22, 2023
COSCIENS Biopharma Inc. (CSCIF)
About this 6-K/A
COSCIENS Biopharma Inc filed this 6-K/A on December 22, 2023.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K/A
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of December 2023
Commission File Number: 001-38064
Aeterna Zentaris Inc.
(Translation of registrant’s name into English)
c/o
Norton Rose Fulbright Canada, LLP,
222 Bay Street, Suite 3000,
PO Box 53, Toronto ON M5K 1E7, Canada
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
EXPLANATORY NOTE
This Amendment No. 1 to the Current Report on Form 6-K/A (this “Form 6-K Amendment”) of Aeterna Zentaris Inc. (the “Company”) is being furnished solely to replace Exhibit 99.15 (the “Notice of Meeting Record Date dated December 18, 2023 (NASDAQ)”) and 99.16 (the “Notice of Meeting Record Date dated December 18, 2023 (Canadian Securities Regulatory Authorities)”) attached to, and incorporated by reference in, the Current Report on Form 6-K originally filed with the U.S. Securities and Exchange Commission (the “SEC”) on December 22, 2023 (the “Original 6-K”) in their entirety to correct the CUSIP/ISIN information of the common shares of the Company listed in such exhibits. The Notices of Meeting and Record Date attached as Exhibits 99.15 and 99.16 to this Form 6-K Amendment are incorporated herein by this reference.
Other than as set forth above, this Form 6-K Amendment to the Original Form 6-K does not amend, update or restate the information in any other item of the Original Form 6-K, or reflect any events that have occurred after the Original Form 6-K was filed with the SEC.
| (2) |
DOCUMENTS INDEX
| Exhibit | Description | |
| 99.15 | Notice of Meeting Record Date dated December 18, 2023 (NASDAQ) | |
| 99.16 | Notice of Meeting Record Date dated December 18, 2023 (Canadian Securities Regulatory Authorities) |
| (3) |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| AETERNA ZENTARIS INC. | ||
| Date: December 22, 2023 | By: | /s/ Giuliano La Fratta |
| Giuliano La Fratta | ||
| Chief Financial Officer | ||
| (4) |
Exhibit 99.15
| December 22, 2023 | AMENDED | 
1500 Robert-Bourassa Blvd., 7th Floor Montreal QC, H3A 3S8 www.computershare.com |
| To: NASDAQ | ||
| Subject: Aeterna Zentaris Inc. | ||
| Dear Sir/Madam: | ||
| We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer: | ||
| Meeting Type : | Special Meeting |
| Record Date for Notice of Meeting : | January 12, 2024 |
| Record Date for Voting (if applicable) : | January 12, 2024 |
| Beneficial Ownership Determination Date : | January 12, 2024 |
| Meeting Date : | February 27, 2024 |
| Meeting Location (if available) : | Virtual Meeting |
| Issuer sending proxy related materials directly to NOBO: | No |
| Issuer paying for delivery to OBO: | Yes |
| Notice and Access (NAA) Requirements: | |
| NAA for Beneficial Holders | No |
| NAA for Registered Holders | No |
| Voting Security Details: | ||||
| Description | CUSIP Number | ISIN | ||
| COMMON SHARES | 007975501 | CA0079755017 | ||
Sincerely,
Computershare
Agent for Aeterna Zentaris Inc.
Exhibit 99.16
| December 22, 2023 | AMENDED | 
1500 Robert-Bourassa Blvd., 7th Floor Montreal QC, H3A 3S8 www.computershare.com |
| To: All Canadian Securities Regulatory Authorities | ||
| Subject: Aeterna Zentaris Inc. | ||
| Dear Sir/Madam: | ||
| We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer: | ||
| Meeting Type : | Special Meeting |
| Record Date for Notice of Meeting : | January 12, 2024 |
| Record Date for Voting (if applicable) : | January 12, 2024 |
| Beneficial Ownership Determination Date : | January 12, 2024 |
| Meeting Date : | February 27, 2024 |
| Meeting Location (if available) : | Virtual Meeting |
| Issuer sending proxy related materials directly to NOBO: | No |
| Issuer paying for delivery to OBO: | Yes |
| Notice and Access (NAA) Requirements: | |
| NAA for Beneficial Holders | No |
| NAA for Registered Holders | No |
| Voting Security Details: | ||||
| Description | CUSIP Number | ISIN | ||
| COMMON SHARES | 007975501 | CA0079755017 |
Sincerely,
Computershare
Agent for Aeterna Zentaris Inc.